Figure 1

Kaplan–Meier estimates of overall survival (OS; a) and radiographic progression-free survival (rPFS; b) in the subsets with and without visceral disease at baseline. AA, abiraterone acetate; P, prednisone; VD, visceral disease; ^atest of homogeneity of the 4 subgroups.